I have been out of the Pit for about 5 years now and these kind of protocols makes me glad I am out.
If a pt looks good, vitals look good, has a cough/crackles, CXR confirms pneumonia. I give them abx and send them out. I don't even do labs. So are docs now labbing/Lactating all of these pts? If so, and if the lactate is >2, then are you really keeping the pt around to check for decompensation/repeat Lactate? So if Lactate creeps up to 3 after 3+hrs, then are you then admitting or are you doing serial Lactates?
I mean, this patient doesn't need admission, and ordering a Lactate puts you into the serial lab abyss.
If a pt comes in looking sick, vitals look terrible, I order labs and admit.
I can say when I stopped working I probably never ordered a lactate level for decision making.
So now say a pt looks sick, you are going to admit, then what is the point of a lactate? If the lactate is normal, then are you discharging? Is the hospitalist not going to admit because its normal eventhough pt looks sick and may decompensate.
I just don't really understand the point other than being on the hook because you discharged someone that fits some criteria.
Medicine has gone nuts. I was taught to treat the pt and not the numbers (obviously to a certain extent). What it looks now is you treat the numbers.
Now, you and I are going to diverge a bit. Lactate certainly plays a role, but our understanding has evolved a bit over the past 25 years. First, a couple of myths:
1) Lactate is a marker of tissue hypoperfusion in sepsis. Unlike entities such as dead gut or global low flow states (cardiogenic, hemorrhagic shock, etc), lactate elevations in sepsis are usually driven by deranged oxidative glycolysis, not anaerobic metabolism. Most people with sepsis have high CI and high DO2 early in the process; global hypoperfusion like we see in cardiogenic shock is relatively uncommon early. Thus, the whole premise of EGDT is flawed because tissue hypoperfusion is an issue in a minority of patients with septic shock.
2) Lactate is a marker of sepsis. No, it has a poor specificity for sepsis and even septic shock. Checking a lactate in every febrile patient is a great way to create gridlock.
3) Lactate is a resuscitative endpoint in septic shock. This is true in shock due to low flow shock states but it’s not the case in most septic shock for much of the same reasons mentioned in #1 above. The reason why lactates tend to improve with fluids in sepsis has more to go with regional, microvascular changes in the kidney and liver, and much less to do with macrovascular hemodynamics. However, the extent to which that lactate goes away is of prognostic significance rather than a therapeutic target; ie if it goes away - great, but don’t pound volume thinking that you must make it go away if the number is not responding.
Once we dispense with those myths, then we’re left with the fact that lactates mostly help us risk-stratify patients who we have already determined to be septic. The is supported by plenty of studies that track increased 30-day mortality with lactate elevations as low as 1.7-2.5 (the better studies say 2-2.5). There is a sharp uptick in in-patient mortality for lactates >4.
So, yes. I check lactates in patients that I think are septic. That includes your older, febrile, tachycardic patient with pneumonia. Most of us are going to pay attention to a lactate greater than 2 in a patient that we have already determined to be septic - even if they look good. That is because the lactate is an independent marker of mortality in these studies that have controlled for other clinical variables (propensity matching or multivariable regression). I can’t say that I personally know any EPs or intensivists outside of this forum who will get the warm fuzzies about discharging someone who we think has sepsis with a lactate that is trending up but otherwise looks good.
Finally, I leave you with the fact that septic shock mortality has significantly improved over the past 30 years; from around 30-40% to 20-25%. If you listen to the investigators running studies like PROCESS, ARISE, etc. it is because we are better identifying sick patients early and bringing to bear therapies faster (antibiotics, source control, etc). It seems intuitively obvious to me that a necessary part of that improvement is that we are admitting certain higher risk patients that we might have otherwise discharged 25 years ago. Is lactate the cornerstone? No, but it is probably playing a role.